Cosmos Health Inc (COSM) is undervalued and Mckesson Corp (MCK) is undervalued.
Against our estimates of intrinsic value, COSM trades at the wider discount: a margin of safety of +52%, against +29% for MCK.
Values as of the 22 Sept 2026 close.
A 1.2x revenue multiple, discounted for its losses, values the shares at $0.73; the price of $0.35 is 52% below that value.
Leak Score 56/100 on 2 of 12 signals
Discounting its cash flows at 7.5% (average of 3 methods) values the shares at $1250.61; the price of $891.23 is 29% below that value, and 82% of that value comes from beyond year five.
Leak Score 78/100 on 8 of 12 signals
| Metric | COSM | MCK |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Price | $0.35 | $891.23 |
| Intrinsic value | $0.73 | $1250.61 |
| Margin of safety | +52% | +29% |
| Leak Score | 56/100 (2/12) | 78/100 (8/12) |
| Market cap | $36M | $103.9B |
| Revenue growth, 5 years | 3.3% | 11.1% |
| Operating margin | -24.6% | 1.6% |
| Net margin | -33.1% | 1.1% |
| Return on equity | -104.0% | — |
| Debt to equity | 0.80 | — |
| P/E | — | 23.9x |
| Forward P/E | 5.1x | 17.6x |
| P/B | 1.4x | — |
| Dividend yield | — | 0.4% |